Journal
CANCER TREATMENT REVIEWS
Volume 35, Issue 7, Pages 590-596Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2009.06.005
Keywords
DNA repair; Cancer therapy; Chemotherapy and radiotherapy resistance; Small molecule inhibitors
Categories
Funding
- Zhejiang Provincial Administration of Traditional Chinese Medicine [2009CA044]
Ask authors/readers for more resources
Increased chemo-resistance and radio-resistance of cancer cells is a major obstacle in the treatment and management of malignant cancers. An important mechanism that underlies the development of such therapeutic resistance is that cancer cells recognize DNA lesions induced by DNA-damaging agents and by ionizing radiation, and repair these lesions by activating various DNA repair pathways. Therefore, Use of pharmacological agents that can inhibit certain DNA repair pathways in cancer cells has the potential for enhancing the targeted cytotoxicity of anticancer treatments and reversing the associated therapeutic resistance associated with DNA repair; such agents, offering a promising opportunity to achieve better therapeutic efficacy. Here we review the major DNA repair pathways and discuss recent advances in the development of novel inhibitors of DNA repair pathways; many of these agents are under preclinical/clinical investigation. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available